Expanding the therapeutic options for renal involvement in lupus: eculizumab, available evidence.
about
Lupus nephritis and B-cell targeting therapy.The renaissance of complement therapeutics.Haemostasis and innate immunity - a complementary relationship: A review of the intricate relationship between coagulation and complement pathways.Antiphospholipid Syndrome Nephropathy: From Pathogenesis to Treatment.Mesenchymal Stem Cells Control Complement C5 Activation by Factor H in Lupus Nephritis.
P2860
Expanding the therapeutic options for renal involvement in lupus: eculizumab, available evidence.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Expanding the therapeutic opti ...... culizumab, available evidence.
@en
type
label
Expanding the therapeutic opti ...... culizumab, available evidence.
@en
prefLabel
Expanding the therapeutic opti ...... culizumab, available evidence.
@en
P2093
P2860
P1476
Expanding the therapeutic opti ...... culizumab, available evidence.
@en
P2093
Dario Roccatello
Irene Cecchi
Jinoos Yazdany
Maria Dall'Era
Massimo Radin
Savino Sciascia
P2860
P2888
P304
P356
10.1007/S00296-017-3686-5
P577
2017-03-03T00:00:00Z
P6179
1084020655